Stanley-Laman Group, Ltd.
Source: SEC Form 13F · as of Mar 2026Stanley-Laman Group, Ltd. holds 18 biotech & pharma companies tracked by BioSniper, totaling $53.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$53.5M
| Company | Shares | Value |
|---|---|---|
| LNTHLantheus Holdings, Inc. | 85,474 | $6.5M |
| LLYELI LILLY & Co | 6,787 | $6.2M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 105,176 | $5.8M |
| MCKMcKesson Corporation | 6,132 | $5.3M |
| AMGNAMGEN INC | 12,465 | $4.4M |
| CORCencora Inc. | 13,336 | $4.2M |
| CPRXCATALYST PHARMACEUTICALS, INC. | 155,021 | $3.8M |
| NBIXNEUROCRINE BIOSCIENCES INC | 27,549 | $3.6M |
| AXSMAxsome Therapeutics, Inc. | 19,260 | $3.3M |
| IONSIONIS PHARMACEUTICALS INC | 39,306 | $3.0M |
| CORTCORCEPT THERAPEUTICS INC | 68,625 | $2.8M |
| RPRXRoyalty Pharma plc | 49,286 | $2.4M |
| MRKMerck & Co., Inc. | 5,916 | $712K |
| ZTSZoetis Inc. | 5,387 | $637K |
| NVSNovartis AG | 2,000 | $306K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 553 | $247K |
| JNJJOHNSON & JOHNSON | 825 | $202K |
| ELVElevance Health Inc. | 666 | $195K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.